Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Elite
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Liver
SUBMITTER: Jiao Guo
LAB HEAD: Jiao Guo
PROVIDER: PXD029867 | Pride | 2022-08-12
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
HFHC-16W-Breviscapine-8W-1.raw | Raw | |||
HFHC-16W-Breviscapine-8W-2.raw | Raw | |||
HFHC-16W-Breviscapine-8W-3.raw | Raw | |||
HFHC-16W-NS-8W-1.raw | Raw | |||
HFHC-16W-NS-8W-2.raw | Raw |
Items per page: 5 1 - 5 of 7 |
Lan Tian T Jiang Shuo S Zhang Jing J Weng Qiqing Q Yu Yang Y Li Haonan H Tian Song S Ding Xin X Hu Sha S Yang Yiqi Y Wang Weixuan W Wang Lexun L Luo Duosheng D Xiao Xue X Piao Shenghua S Zhu Qing Q Rong Xianglu X Guo Jiao J
Hepatology (Baltimore, Md.) 20211219 1
<h4>Background and aims</h4>NAFLD is a key component of metabolic syndrome, ranging from nonalcoholic fatty liver to NASH, and is now becoming the leading cause of cirrhosis and HCC worldwide. However, due to the complex and unclear pathophysiological mechanism, there are no specific approved agents for treating NASH. Breviscapine, a natural flavonoid prescription drug isolated from the traditional Chinese herb Erigeron breviscapus, exhibits a wide range of pharmacological properties, including ...[more]